| For: | Bhat S, Fernandez CJ, Lakshmi V, Pappachan JM. Efficacy and safety of incretin co-agonists: Transformative advances in cardiometabolic healthcare. World J Cardiol 2025; 17(8): 107991 [PMID: 40949933 DOI: 10.4330/wjc.v17.i8.107991] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v17/i8/107991.htm |
| Number | Citing Articles |
| 1 |
Yange Meng, Ting Jin, Luping Ren, Michelle L. Thompson, Yue Wang. Comparative Efficacy and Safety of Semaglutide, Cagrilintide, and CagriSema in Adults with Overweight or Obesity: A Bayesian Network Meta-Analysis. Journal of Clinical Question 2025; 2(6): e94 doi: 10.69854/jcq.2025.0033
|
| 2 |
Urna Kansakar, Stanislovas S. Jankauskas, Shivangi Pande, Pasquale Mone, Fahimeh Varzideh, Gaetano Santulli. Orforglipron: A Comprehensive Review of an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity and Type 2 Diabetes. International Journal of Molecular Sciences 2026; 27(3): 1409 doi: 10.3390/ijms27031409
|
